Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
INDUSTRY
×
Adenomatous Polyposis Coli
×
Clear all
Filters
3
NCT06950385
2026-03-17
SERENTA
Rapamycin Holdings Inc.
Phase 3
Recruiting
168 enrolled
NCT05552755
2025-12-04
TUPELO
Recursion Pharmaceuticals Inc.
Phase 1/2
Recruiting
67 enrolled